Guidelines on Active Pharmaceutical Ingredient (API)

Hits: 15505

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

 

Document Name Download Updated
DRGD - Appendix 11 : Regulatory Control Of Active Pharmaceutical Ingredients (APIs) Jan-2021
Guidance Notes for API Information for Product Registration Application via QUEST (Version 6.0) Mar-2021
List of Updates for Guidance Notes  Mar-2021
Guideline on Submission of Documentation for a Multisource (Generic) Finished Pharmaceutical Product (FPP):Quality Part. Jan-2012
WHO Technical Report Series, No. 953, 2009 Annex 2: 
Stability testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products		 Jan-2009

 

API-Main-Page-Button

Rating:
( 4 Ratings )

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Friday 15 October 2021, 15:58:04.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

API Menu

Main Menu English

Choose Your Language